Venus Remedies secures marketing authorization from Serbia for gemcitabine and docetaxel

20 Sep 2023 Evaluate

Venus Remedies has secured marketing authorization from Serbia for gemcitabine and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer. With this, the company has secured 511 marketing approvals for its oncology products across 66 countries.

Extending its reach in the Balkans and Eastern Europe, Venus Remedies secured a marketing authorization for gemcitabine from Bosnia a few months ago, which was followed by marketing approvals for docetaxel from Georgia and two other key cancer drugs from Moldova.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.


Venus Remedies Share Price

818.15 33.50 (4.27%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×